This inventor holds 1 USPTO granted patent. Top assignee: Newgen Therapeutics, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: **Innovative Contributions of Junfa Fan in Pharmaceutical Development**
Introduction
Junfa Fan, an accomplished inventor based in Hayward, California, has made significant strides in the field of pharmaceutical development. With a focus on addressing hyperproliferative diseases, particularly cancer, he has contributed to advancing medical treatments through his inventive work.
Latest Patents
Junfa Fan holds a patent for "Phosphorus containing quinazoline compounds and methods of use." This groundbreaking invention discloses novel quinazoline derivatives featuring phosphorus substitutions that target the treatment of hyperproliferative diseases, such as cancer. The compounds serve as type I receptor protein kinase inhibitors, which prove useful in treating disorders linked to abnormal protein kinase activities, including cancer and inflammation in mammals. Moreover, the patent outlines pharmaceutical compositions containing these compounds, as well as methods for their preparation and the formulation of their pharmaceutically acceptable salts.
Career Highlights
As an inventor at Newgen Therapeutics, Inc., Junfa Fan has leveraged his expertise to innovate within the pharmaceutical industry. His contributions not only focus on the scientific discovery of new drugs but also emphasize developing practical applications that can significantly benefit public health.
Collaborations
In his endeavors, Junfa Fan has worked alongside notable colleagues, including Wang Shen and Aimin Zhang. Together, they have fostered a collaborative environment that facilitates the advancement of cutting-edge research and the successful development of therapeutic solutions.
Conclusion
Junfa Fan's work exemplifies the potential of innovative thinking in addressing some of the most pressing health challenges of our time. Through his patented inventions and collaborative efforts, he has positioned himself as a key figure in the pharmaceutical industry, marking a meaningful impact on the fight against cancer and related diseases.